{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-005042","form_type":"8-K","ticker":"NERV","cik":"0001598646","company_name":"Minerva Neurosciences, Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.120271+00:00","generated_at":"2026-05-28T03:22:10.960013+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nasdaq Panel grants Minerva continued listing subject to equity compliance by March 31, 2025","bullets":["Company must file disclosure on transactions to meet $2.5M minimum stockholders' equity by 3/31/25.","Must also provide 12-month income projections with underlying assumptions to Panel by same deadline.","Company is working toward compliance but states no assurance of regaining or maintaining listing.","Original deficiency was market value below $35M; now equity compliance is the key condition."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-005042","json":"https://secwatch.observer/filing/0001193125-25-005042.json","markdown":"https://secwatch.observer/filing/0001193125-25-005042.md","text":"https://secwatch.observer/filing/0001193125-25-005042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1598646/000119312525005042/0001193125-25-005042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1598646/000119312525005042/d906093d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:22:10.960013+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}